Cupps Capital Management’s Allergan plc AGN Stock Holding History

Cupps Capital Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-583	Closed	-$158K	–	207
2015 Q3	$158K	Buy	+583	New	+$179K	0.02%	140
2015 Q2	–	Sell	-35	Closed	-$10K	–	233
2015 Q1	$10K	Hold	35	–	–	﹤0.01%	170
2014 Q4	$9K	Hold	35	–	–	﹤0.01%	184
2014 Q3	$8K	Buy	35 +12	+52%	+$2.69K	﹤0.01%	180
2014 Q2	$5K	Hold	23	–	–	﹤0.01%	176
2014 Q1	$4K	Buy	+23	New	+$4.56K	﹤0.01%	179
2013 Q4	–	Sell	-23	Closed	-$3K	–	184
2013 Q3	$3K	Hold	23	–	–	﹤0.01%	167
2013 Q2	$2K	Buy	+23	New	+$2.6K	﹤0.01%	178

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Cupps Capital Management's AGN Position: Q4 2015 in Review

Cupps Capital Management sold out of Allergan plc (AGN) in Q4 2015, closing a stake of 583 shares — an estimated $158K sold.

Cupps Capital Management first reported a position in AGN in Q2 2013 and held it in 8 quarters. The position peaked at $158K in Q3 2015. 1,110 funds tracked by Wall St. Rank hold AGN as of Q4 2015.

Cupps Capital Management reported no remaining Allergan plc position as of Q4 2015 after selling out during the quarter.
Cupps Capital Management sold 583 Allergan plc shares in Q4 2015, an estimated $158K.
Cupps Capital Management first reported a position in Allergan plc in Q2 2013 and held it in 8 quarters.
Cupps Capital Management's Allergan plc position peaked at $158K in Q3 2015.
1,110 funds tracked by Wall St. Rank held Allergan plc as of Q4 2015.

Based on Cupps Capital Management's 13F filing for Q4 2015, filed 11 Feb 2016.